Structures of 5-bromo-6-ethoxy-5,6-dihydrouridine and -thymidine derivatives, a class of potential antitumoral and antiviral N-nucleosides. 1989

G Bernardinelli, and R Benhamza, and J M Tronchet
Laboratoire de Cristallographie aux rayons X, Université de Genève, Switzerland.

(I): (+)-(5R,6R)-5-Bromo-6-ethoxy-5,6-dihydro-2',3'-isopropylidene-beta-D- ribofuranosyl-uracil, C14H21BrN2O7, m.p. 408.7-409.6 K, [alpha]D23 degrees C = +31.1 degrees (c = 1.2% in MeOH), Mr = 409.2, monoclinic, P2(1), a = 9.218 (2), b = 9.6619(11) c = 10.4938 (14) A, beta = 99.305 (8) degrees, V = 922.4 (2) A3, Z = 2, Dx = 1.47 Mgm-3, lambda (Mo K alpha) = 0.71069 A, mu = 2.24 mm-1, F(000) = 420, room temperature, R (= wR) = 0.046 for 2595 observed reflections [(Fo)] greater than 4 sigma (Fo) and (Fo) greater than 8.0]. (II): (+)-(5R,6R)-5-Bromo-2'-deoxy-6-ethoxy-5,6-dihydro-beta-D-ribofuranosyl- thymine, C12H19BrN2O6, m.p. 376.1-376.5 K, [alpha]D 23 degrees C = + 58.8 degrees (c = 1.02% in MeOH), Mr = 367.2, monoclinic, clinic, P21, a = 6.0428 (9), b = 8.5270 (15), c = 14.589 (2) A, beta = 96.80 (1) degrees, V = 746.4 (1) A3, Z = 2, Dx = 1.63 Mg m-3, lambda(Mo K alpha) = 0.71069 A, mu = 2.75 mm-1, F(000) = 376, room temperature, R = 0.053 (wR = 0.040) for 1579 observed reflections [[F0[ less than 4 sigma(Fo)]. Both furanose rings adopt an envelope conformation with C(4')-exo and C(1')-exo for (I) and (II) respectively. The orientation of the dihydropyrimidine base relative to the sugar ring shows an unusual syn conformation [chi CN = 62.5 (6) degrees] for (I) whereas the glycosyl linkage of compound (II) shows an anti conformation [chi CN = -134.0 (8) degrees]. In both compounds the pyrimidine ring displays a half-chair form. The conformation of the hydroxymethyl group at C(4') is gauche-gauche for (I) [phi OO = -68.2 (7) degrees, phi OC = 50.1 (8) degrees] and trans-gauche for (II) [phi OO = 180 (1) degrees, phi OC = -61 (1) degrees]. The absolute configuration of (I) was confirmed by least-squares refinement of x [x = 0.008 (16)] [Bernardinelli & Flack (1985). Acta Cryst. A41, 500-511] and that of compound (II) deduced from the starting material. An intramolecular hydrogen bond occurs between the hydroxymethyl and the pyrimidine of (I). In both structures, the molecular packing is fixed by a network of hydrogen bonds.

UI MeSH Term Description Entries
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D014529 Uridine A ribonucleoside in which RIBOSE is linked to URACIL. Allo-Uridine,Allouridine,Allo Uridine
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions

Related Publications

G Bernardinelli, and R Benhamza, and J M Tronchet
February 2002, Bioorganic & medicinal chemistry letters,
G Bernardinelli, and R Benhamza, and J M Tronchet
February 1995, Drug metabolism and disposition: the biological fate of chemicals,
G Bernardinelli, and R Benhamza, and J M Tronchet
October 1975, Carbohydrate research,
G Bernardinelli, and R Benhamza, and J M Tronchet
December 2006, Molecules (Basel, Switzerland),
G Bernardinelli, and R Benhamza, and J M Tronchet
July 1971, Journal of the American Chemical Society,
G Bernardinelli, and R Benhamza, and J M Tronchet
April 1976, Journal of the American Chemical Society,
G Bernardinelli, and R Benhamza, and J M Tronchet
July 1994, Drug design and discovery,
G Bernardinelli, and R Benhamza, and J M Tronchet
July 1981, Biochimica et biophysica acta,
G Bernardinelli, and R Benhamza, and J M Tronchet
April 2008, Chemical research in toxicology,
G Bernardinelli, and R Benhamza, and J M Tronchet
January 1974, Chemotherapy,
Copied contents to your clipboard!